Sign in: Staff/Students
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Neurodegeneration involves the progressive loss of nerve structure and function and is a common characteristic of several conditions, including Parkinson’s, Alzheimer’s and Huntington’s. Such diseases are presently incurable.
Researchers from the University’s Institute of Translational Medicine have found that the anti-epileptic drug ethosuximide has protective effects in certain neurodegenerative disease models.
Making a difference
Professor of Cellular and Molecular Physiology, Alan Morgan, said: “Incidence of these diseases is on the rise due to our increasingly ageing population, yet there is a lack of effective therapies to treat them.
“Our research suggests that ethosuximide has potential for repurposing as a treatment for multiple neurodegenerative diseases and provides a platform from which new medicines could be developed.
“Indeed, we are now actively pursuing this in current research with colleagues Professor Bob Burgoyne and PhD student, Shi Quan Wong. Eventually, we hope that our work will make a difference to those suffering from these debilitating diseases.”
The study was funded by grants from the BBSRC, the Wellcome Trust and Age UK.
The paper ‘Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression’ was published in the journal Molecular Neurodegeneration and can be accessed here: http://bit.ly/1VAFn7v
You must be logged in to post a comment.
All recent news
Insider Imprint: New Issue of student-centred Life Sciences journal
Gaelic football club gives back to local community
Reminder: Being mindful of our neighbours
GALLERY: Digital Innovation Facility opening
Students’ bold designs that would transform Liverpool’s city centre
Becoming an Expert: Wei Huang is a 4th year PhD student with the Trustworthy Autonomous Cyber-Physical Systems Laboratory located in the Digital Innovation Facility➡️http://bit.ly/3MOJS0z
Congratulations to Professor Tom Solomon on his appointment as the new Director of The Pandemic Institute! Read more about this story and the exciting new funding call focusing on the unprecedented spread of monkey pox outside of African countries here: https://tinyurl.com/PandemicInstituteDirector
Dr @farnaznickpour & @inclusionaries_ lab are part of an innovative project with @DuchenneUK & @SMA_UK awarded £1.25M from @PostcodeLottery to design a revolutionary upper body mobility suit for progressive neuromuscular diseases.
Find out more: http://bit.ly/3LKjtQb